Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boortmalt is the world's leading malting company, producing high-quality malt for the global brewing and distilling industries. As a primary subsidiary of the French agricultural cooperative Axéréal, the company operates 27 malting plants across five continents. With an annual production capacity of approximately 3 million tonnes, it serves major international brewers and craft distillers alike. The company is a central figure in the agricultural supply chain, emphasizing sustainable barley procurement and innovative processing technologies. Boortmalt achieved its market-leading position through strategic growth, most notably the 2019 acquisition of Cargill's global malt business.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boortmalt.